Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT

Bone Marrow Transplantation volume 48, pages 80–84 (2013)Cite this article

Subjects

Abstract

There are no well-defined studies of chronic kidney disease (CKD) among long-term survivors after hematopoietic SCT. A retrospective longitudinal study was conducted to characterize CKD in 77 subjects that had undergone myeloablative allogeneic SCT, all of whom had their serum creatinine (Cr) levels followed-up during the 10-year period after SCT. Their mean (range) survival time was 14.4 (10.5–20.2) years. CKD was defined as a persistent decrease in the Cr-based estimated glomerular filtration rate to below 60 mL/min/1.73 m2. Acute kidney injury (AKI) was defined as an increase in Cr within the first 100 days after SCT, and its severity was classified into three stages according to the AKIN criteria. Kaplan–Meier and Cox proportional hazards regression analyses evaluated the association between AKI and the incidence of CKD. The cumulative incidence of CKD increased over time and reached 34% at 10 years. After adjusting for known risks for post-SCT CKD, each AKIN stage was strongly associated with the incidence of CKD. The incidence of CKD probably increases over time among subjects who are alive at >10 years after SCT. This study places a new emphasis on AKI as an important risk factor for CKD in post-SCT subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C et al. Cardiovascular mortality risk in chronic kidney disease. JAMA 2005; 293: 1737–1745.

    Article  CAS  PubMed  Google Scholar 

  2. James MT, Quan H, Tonelli M . CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009; 54: 24–32.

    Article  PubMed  Google Scholar 

  3. Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol 2009; 20: 1341–1350.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE . End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 1998; 79: 408–412.

    Article  CAS  PubMed  Google Scholar 

  5. Humphreys BD . Renal complications of hematopoietic stem cell transplantation. http://www.nephrologyrounds.org/crus/nephUS_060706.pdf. Accessed January, 2012.

  6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1–266.

    Google Scholar 

  7. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.

    Article  CAS  PubMed  Google Scholar 

  8. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31–R38.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Igaki H, Karasawa K, Sakamaki H, Saito H, Nakagawa K, Ohtomo K et al. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks. Strahlenther Onkol 2005; 181: 704–708.

    Article  PubMed  Google Scholar 

  10. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.

    Google Scholar 

  11. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  12. Hingorani S . Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 2006; 17: 1995–2005.

    Article  PubMed  Google Scholar 

  13. Choi M, Sun CL, Kurian S, Carter A, Francisco L, Forman SJ et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 2008; 113: 1580–1587.

    Article  PubMed  Google Scholar 

  14. Kersting S, Hené RJ, Koomans HA, Verdonck LF . Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1169–1175.

    Article  PubMed  Google Scholar 

  15. Munakata W, Sawada T, Kobayashi T, Kakihana K, Yamashita T, Ohashi K et al. Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution. Int J Hematol 2011; 93: 517–522.

    Article  CAS  PubMed  Google Scholar 

  16. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR . Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961–973.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ishanai A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223–228.

    Article  Google Scholar 

  18. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W et al. Incidence and outcome in acute kidney injury: A comprehensive population-based study. J Am Soc Nephrol 2007; 18: 1292–1298.

    Article  CAS  PubMed  Google Scholar 

  19. Hoste EA, Clermount G, Kersten A, Venkataraman R, Angus DC, Bacquer DD et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73–R82.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD . Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008; 8: 2378–2390.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB . Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223–229.

    Article  CAS  PubMed  Google Scholar 

  22. Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 2010; 25: 278–282.

    Article  PubMed  Google Scholar 

  23. Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 1991; 67: 2795–2800.

    Article  CAS  PubMed  Google Scholar 

  24. Cohen EP, Lawton CA, Moulder JE . Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 1995; 70: 217–222.

    Article  CAS  PubMed  Google Scholar 

  25. Cohen EP . Radiation nephropathy after bone marrow transplantation. Kidney Int 2000; 58: 903–918.

    Article  CAS  PubMed  Google Scholar 

  26. Kal HB, van Kempen-Harteveld ML . Renal dysfunction after total body irradiation: dose-effect relationship. Int J Radiat Oncol Biol Phys 2006; 65: 1228–1232.

    Article  PubMed  Google Scholar 

  27. Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996; 14: 579–585.

    Article  CAS  PubMed  Google Scholar 

  28. Naesens M, Kuypers DR, Sarwal M . Calcineurin Inhibitor Nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481–508.

    CAS  PubMed  Google Scholar 

  29. Moulder JE, Fish BL, Cohen EP . Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr Pharm Des 2007; 13: 1317–1325.

    Article  CAS  PubMed  Google Scholar 

  30. Ichida S, Okada K, Itoh M, Okada R, Katoh N, Kasai M et al. Bone marrow transplant nephropathy successfully treated with angiotensin-converting enzyme inhibitor. Clin Exp Nephrol 2006; 10: 78–81.

    Article  PubMed  Google Scholar 

  31. Imai E, Masaru H, Kosaku N, Kunihiro Y, Kunitoshi I, Shigeko H et al. Estimation of glomerular fi ltration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41–50.

    Article  PubMed  Google Scholar 

  32. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927–937.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Drs Takuya Yamashita and Jinichi Mori for their invaluable participation in this study.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Nephrology, Tokyo Metropolitan Cancer Center, Komagome Hospital, Tokyo, Japan

    T Shimoi & M Ando

  2. Department of Medicine, Division of Hematology, Tokyo Metropolitan Cancer Center, Komagome Hospital, Tokyo, Japan

    T Shimoi, W Munakata, T Kobayashi, K Kakihana, K Ohashi, H Akiyama & H Sakamaki

Authors
  1. T Shimoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Munakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Kakihana
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K Ohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H Sakamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Ando.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimoi, T., Ando, M., Munakata, W. et al. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT. Bone Marrow Transplant 48, 80–84 (2013). https://doi.org/10.1038/bmt.2012.85

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.85

Keywords

This article is cited by

Search

Advanced search

Quick links